| Dr Eric Eduardo Vargas, DPT | |
|
4200 Somerset Dr., Suite 244, Leawood, KS 66206 | |
| (913) 391-7288 | |
| Not Available |
| Full Name | Dr Eric Eduardo Vargas |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 4200 Somerset Dr., Leawood, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114587318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 11-06212 (Kansas) | Primary |
| Provider Name | Truefix Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1326614736 PECOS PAC ID: 1557720885 Enrollment ID: O20230705003189 |
News Archive
Human Genome Sciences, Inc. and Lonza today announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE). BENLYSTA is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in 2006.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant Canada Limited, has received notice that the New Drug Submission for Sublinox has been approved from the Canadian regulatory authority Health Canada.
A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.
A new analysis of published studies found a 45% increased risk of congenital heart defects in newborns when women become pregnant via in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) than through spontaneous conception.
Researchers from the University of Leicester and Leicester's Hospitals have discovered that many people suffering from type 2 diabetes also suffer from low blood sugar levels that can pose a significant risk to their health.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Eduardo Vargas, DPT 2004 W 84th St, Leawood, KS 66206-1504 Ph: (913) 461-7418 | Dr Eric Eduardo Vargas, DPT 4200 Somerset Dr., Suite 244, Leawood, KS 66206 Ph: (913) 391-7288 |
News Archive
Human Genome Sciences, Inc. and Lonza today announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under regulatory review in the United States and Europe as a potential new treatment for systemic lupus erythematosus (SLE). BENLYSTA is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in 2006.
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant Canada Limited, has received notice that the New Drug Submission for Sublinox has been approved from the Canadian regulatory authority Health Canada.
A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.
A new analysis of published studies found a 45% increased risk of congenital heart defects in newborns when women become pregnant via in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) than through spontaneous conception.
Researchers from the University of Leicester and Leicester's Hospitals have discovered that many people suffering from type 2 diabetes also suffer from low blood sugar levels that can pose a significant risk to their health.
› Verified 4 days ago
Emily Tomlinson, PT, DPT, OCS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3651 College Blvd, Leawood, KS 66211 Phone: 913-253-1760 | |
Nancy Diehl, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3651 College Blvd, Leawood, KS 66211 Phone: 913-253-8980 | |
Gerald Jay Marquette, RPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 13420 Briar Dr Ste C, Leawood, KS 66209 Phone: 913-484-7632 Fax: 913-808-5460 | |
Dr. Katherine Plunkett, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8900 State Line Rd, Suite 333, Leawood, KS 66206 Phone: 913-491-9404 Fax: 913-754-0365 | |
Playabilities Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3715 W 133rd St, Leawood, KS 66209 Phone: 913-515-3531 Fax: 816-222-0679 | |
Erik Michael Hansen, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 13016 Linden St, Leawood, KS 66209 Phone: 913-226-9240 | |
Cody Wiley Sliva, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5241 W 151st Ter, Leawood, KS 66224 Phone: 913-270-6187 |